Click to rate this post!
[Total: 0 Your Rating: 0]You must sign in to vote
Fisher Wallace Laboratories
Regulation A+ Offering
Medical Devices for Mood and Sleep
$967,211 Raised | 597 Investors
$496.80 Min. Investment
The Fisher Wallace Stimulator comfortably stimulates the brain to produce serotonin and modulate brainwave activity to help patients struggling with depression, anxiety and insomnia. The device has demonstrated a high effectiveness rate and less than a 1% side effect rate in clinical practice. Reasons to invest in Fisher Wallace include:
Path to FDA Approval: With three clinical trials underway to support the approval process, Fisher Wallace was recently granted over-the-counter approval in Europe and Medicaid approval in Maine (MaineCare).
Improved Margins: Fisher Wallace successfully migrated its manufacturing to a high-volume facility that has reduced its cost of goods sold (COGS) by 60%.
Patients who use the device for 20 minutes once or twice a day typically experience symptom reduction within the first week of use. You can invest in Fisher Wallace for as little as $496.80.
Learn More About Fisher Wallace